Fast Track vs Accelerated Approval | FDA Expedited Programs Explained Simply

🚀 Fast Track Designation and Accelerated Approval are two of the most important FDA expedited programs—but they are often confused. In this session, we break down the key differences between these programs and explain how they help bring important therapies to patients faster. You'll learn: ✅ What Fast Track Designation is ✅ Eligibility criteria for Fast Track ✅ Benefits of Fast Track, including Rolling Review ✅ What Accelerated Approval is ✅ Surrogate and Intermediate Clinical Endpoints ✅ Confirmatory (Phase 4) Trials ✅ FDA withdrawal of approval when benefits are not confirmed ✅ Fast Track vs Accelerated Approval – Side-by-Side Comparison ✅ Common interview and regulatory affairs questions This session is ideal for: 🎯 Regulatory Affairs Professionals 🎯 Regulatory Affairs Students 🎯 Clinical Research Professionals 🎯 Pharmacovigilance Professionals 🎯 Pharmaceutical Industry Employees 🎯 Candidates Preparing for Regulatory Affairs Interviews 📌 Key Takeaway: 🚆 Fast Track = Faster Development ⚡ Accelerated Approval = Earlier Approval Understanding this distinction is essential for anyone working in pharmaceutical regulatory affairs and drug development. #RegulatoryAffairs #FDA #FastTrackDesignation #AcceleratedApproval #DrugDevelopment #ClinicalTrials #PharmaceuticalIndustry #Biotech #RegulatoryScience #NDA #BLA #RegulatoryResearchCentre